|
| | HB2043 Engrossed | | LRB097 08980 KTG 49113 b |
|
|
| 1 | | AN ACT concerning aging.
|
| 2 | | Be it enacted by the People of the State of Illinois,
|
| 3 | | represented in the General Assembly:
|
| 4 | | Section 5. The Senior Pharmaceutical Assistance Act is |
| 5 | | amended by changing Section 15 as follows:
|
| 6 | | (320 ILCS 50/15)
|
| 7 | | Sec. 15. Senior Pharmaceutical Assistance Review |
| 8 | | Committee.
|
| 9 | | (a) The Senior Pharmaceutical Assistance Review Committee |
| 10 | | is
created. The Committee shall consist of 17 members as |
| 11 | | follows:
|
| 12 | | (1) Twelve members appointed as follows: 2 members of |
| 13 | | the General
Assembly and 1 member of the general public, |
| 14 | | appointed by the President of the
Senate; 2 members of the |
| 15 | | General Assembly and 1 member of the general public,
|
| 16 | | appointed by the Minority Leader of the Senate; 2 members |
| 17 | | of the General
Assembly and 1 member of the general public, |
| 18 | | appointed by the Speaker of the
House of Representatives; |
| 19 | | and 2 members of the General Assembly and 1 member of
the |
| 20 | | general public, appointed by the Minority Leader of the |
| 21 | | House of
Representatives.
These members shall serve at the |
| 22 | | pleasure of the appointing authority.
|
| 23 | | (2) The Director of Aging or his or her designee.
|
|
| | HB2043 Engrossed | - 2 - | LRB097 08980 KTG 49113 b |
|
|
| 1 | | (3) The Director of Revenue or his or her designee.
|
| 2 | | (4) The Director of Healthcare and Family Services or |
| 3 | | his or her designee.
|
| 4 | | (5) The Secretary of Human Services or his or her |
| 5 | | designee.
|
| 6 | | (6) The Director of Public Health or his or her |
| 7 | | designee.
|
| 8 | | (b) Members appointed from the general public shall |
| 9 | | represent the
following associations, organizations, and |
| 10 | | interests: statewide
membership-based senior advocacy |
| 11 | | organizations, pharmaceutical manufacturers,
pharmacists,
|
| 12 | | dispensing pharmacies, physicians, and providers of services |
| 13 | | to senior
citizens.
No single organization may have more than |
| 14 | | one representative appointed as a
member from the general |
| 15 | | public.
|
| 16 | | (c) The President of the Senate and Speaker of the House of
|
| 17 | | Representatives shall each designate one member of the |
| 18 | | Committee to serve as
co-chairs.
|
| 19 | | (d) Committee members shall serve without compensation or
|
| 20 | | reimbursement for expenses.
|
| 21 | | (e) The Committee shall meet at the call of the co-chairs, |
| 22 | | as deemed necessary but at
least quarterly.
|
| 23 | | (f) The Committee may conduct public hearings to gather |
| 24 | | testimony
from interested parties regarding pharmaceutical |
| 25 | | assistance for Illinois
seniors, including changes to existing |
| 26 | | and proposed programs.
|
|
| | HB2043 Engrossed | - 3 - | LRB097 08980 KTG 49113 b |
|
|
| 1 | | (f-5) The Committee may review federal legislation with |
| 2 | | regard to e-prescribing to determine what provisions, if any, |
| 3 | | would improve health care in Illinois. |
| 4 | | (f-6) The Committee may conduct public hearings to gather |
| 5 | | testimony regarding federal procedure for pandemic |
| 6 | | preparedness and response to determine whether or not the State |
| 7 | | should update its preparedness procedures and tactics. |
| 8 | | (g) The Committee may advise appropriate State agencies |
| 9 | | regarding
the establishment of proposed programs or changes to |
| 10 | | existing programs. The
State agencies shall take into |
| 11 | | consideration any recommendations made by the
Committee.
|
| 12 | | (h) The Committee shall report to the General Assembly and |
| 13 | | the
Governor annually or as it deems necessary regarding |
| 14 | | proposed or recommended
changes to pharmaceutical assistance |
| 15 | | programs that benefit Illinois seniors and
any associated costs |
| 16 | | of those changes.
|
| 17 | | (h-5) The Committee may conduct public hearings to gather |
| 18 | | testimony from interested parties regarding prescription drug |
| 19 | | abuse to determine whether the State should increase penalties |
| 20 | | against those engaged in conduct potentially harmful to |
| 21 | | Illinois residents, particularly those under age 25. In order |
| 22 | | to do this, the Committee may review guidelines from State |
| 23 | | universities addressing prescription drug abuse. |
| 24 | | (i) In the event that a prescription drug benefit is added |
| 25 | | to the federal
Medicare
program, the Committee shall make |
| 26 | | recommendations for the realignment of State-operated senior |
|
| | HB2043 Engrossed | - 4 - | LRB097 08980 KTG 49113 b |
|
|
| 1 | | prescription drug programs so
that Illinois residents qualify |
| 2 | | for at least substantially the same level of benefits
available |
| 3 | | to them prior
to implementation of the Medicare prescription |
| 4 | | drug benefit, provided that a resident remains eligible for |
| 5 | | such a State-operated program. The Committee shall report its |
| 6 | | recommendations to the General
Assembly and
the Governor by |
| 7 | | January 1, 2005.
|
| 8 | | (Source: P.A. 95-331, eff. 8-21-07; 96-1183, eff. 7-22-10.)
|
| 9 | | Section 99. Effective date. This Act takes effect upon |
| 10 | | becoming law.
|